Tubal Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2012-12-05
Clinical Trial Update: Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer [Phase 2]
The Phase 2 study evaluating the combination of Iressa (gefitinib) and Anastrozole (Arimidex) in ovarian, peritoneal, and tubal carcinomas h…